Everything is still moving forward except for those that are jumping ship because they don’t understand the drug development and approval process. If they think there is another drug candidate with Brilacidin’s abilities that is ready to go into human trials for COVID-19, they are sadly mistaken. The number of cases are quickly climbing and ICUs are becoming overwhelmed. The virus is not going away anytime soon, so Brilacidin is not going away anytime soon. If anything, as desperation continues to increase, so will the demand for Brilacidin.